
Actorise 40 Injection
Marketer
Cipla Ltd
Salt Composition
Darbepoetin alfa (40mcg)
Overview Actorise 40 Injection
Erythropoiesis-stimulating injection, Actorise 40, treats anemia stemming from chronic kidney disease or chemotherapy. Its mechanism involves bone marrow stimulation for increased red blood cell production. Administered under strict medical supervision, Actorise 40 necessitates careful usage due to potential serious adverse reactions. Expert medical guidance is essential; patients must adhere rigorously to their physician's instructions. Elevated blood pressure and hypersensitivity reactions are possible. Report severe headache, visual disturbances, nausea, vomiting, or seizures (indicative of dangerously high blood pressure) immediately. Regular blood tests (monitoring electrolytes like potassium, hemoglobin, and blood cell counts) will be conducted. Discontinue use and consult your doctor if shortness of breath or a skin rash develops. A patient support program, facilitated by Tata 1mg, is accessible in India. Inquire with your doctor or call 1800-102-1618 for further information.
Uses of Actorise 40 Injection
Managing anemia in chronic kidney disease patients | Addressing chemotherapy-induced anemia
Major Benefits of Actorise 40 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Actorise 40 Injection:
- Abdominal pain
- High blood pressure
- Rash
- Injection site pain
- Breathlessness
- Cough
- Peripheral edema
- Procedural hypotension (low blood pressure)
- Convulsion
- Thromboembolism
How to use Actorise 40 Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Actorise 40 Injection works:
Actorise 40 Injection is an erythropoietin-based medication that boosts red blood cell production. It achieves this by prompting increased red blood cell generation within the bone marrow, the blood-cell-producing tissue inside bones.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Actorise 40 Injection may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Actorise 40 Injection during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The administration of Actorise 40 Injection while breastfeeding is likely inadvisable. Available evidence in humans indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Actorise 40 Injection.
KidneySAFE IF PRESCRIBED
For patients with kidney impairment, Actorise 40 Injection poses no safety concerns. No alteration of the Actorise 40 Injection dosage is advised.
LiverCAUTION
The use of Actorise 40 Injection requires careful consideration in individuals with hepatic impairment. Dosage modification of Actorise 40 Injection might be necessary. Physician consultation is advised.
What if you forget to take Actorise 40 Injection :
Should you forget a dose of Actorise 40 Injection, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Actorise 40 Injection
| Label | Value |
|---|---|
| Chemical Type | Amino Acid and Peptide Analogs |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | Erythropoietin-stimulating drug |
